Getagraph.com logo
S&P 500 Futures
(-0.47%) 5 025.50 points
Dow Jones Futures
(-0.38%) 37 861 points
Nasdaq Futures
(-0.71%) 17 423 points
Oil
(-0.33%) $82.46
Gas
(-0.34%) $1.751
Gold
(-0.05%) $2 396.80
Silver
(-0.19%) $28.33
Platinum
(-1.13%) $943.70
USD/EUR
(-0.09%) $0.938
USD/NOK
(-0.05%) $11.04
USD/GBP
(-0.04%) $0.804
USD/RUB
(-0.77%) $93.18

Realtime updates for Lumos Pharma Inc [LUMO]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Last Updated18 Apr 2024 @ 16:00
25% discount on Stockinvest.us - Use code: Podcast

6.50% $ 2.62

Live Chart Being Loaded With Signals

Commentary (18 Apr 2024 @ 16:00):

Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare endocrine disorders...

Stats
Today's Volume 12 347.00
Average Volume 19 953.00
Market Cap 21.24M
EPS $0 ( 2024-03-07 )
Next earnings date ( $-1.210 ) 2024-05-01
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.630
ATR14 $0.0320 (1.22%)
Insider Trading
Date Person Action Amount type
2024-01-04 Pitukcheewanont Pisit Duke Sell 0 Common Stock
2023-06-01 Pitukcheewanont Pisit Duke Sell 29 750 Stock Option (Right to Buy)
2024-02-01 Pitukcheewanont Pisit Duke Sell 3 333 Stock Option (Right to Buy)
2024-07-01 Pitukcheewanont Pisit Duke Sell 25 500 Stock Option (Right to Buy)
2023-08-01 Mckew John C. Sell 1 593 Common Stock
INSIDER POWER
24.05
Last 99 transactions
Buy: 596 623 | Sell: 145 033

Lumos Pharma Inc Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Lumos Pharma Inc Financials

Annual 2023
Revenue: $2.05M
Gross Profit: $2.01M (97.85 %)
EPS: $-4.18
Q4 2023
Revenue: $826 000
Gross Profit: $808 000 (97.82 %)
EPS: $-1.170
Q3 2023
Revenue: $7 000.00
Gross Profit: $-1 000.00 (-14.29 %)
EPS: $-1.040
Q2 2023
Revenue: $527 000
Gross Profit: $518 000 (98.29 %)
EPS: $-1.090

Financial Reports:

No articles found.

Lumos Pharma Inc

Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare endocrine disorders. The company is headquartered in Austin, Texas.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators